South Sudan Fights Malaria Drug Resistance With New Data

Scientists in South Sudan are using DNA detective work to outsmart malaria before drug resistance becomes unstoppable.

The country faces a serious challenge. Malaria causes 38 percent of all clinic visits and 64 percent of hospital deaths. Now resistance to the main treatment drugs is creeping across East Africa, threatening to make those numbers worse.

But South Sudan isn't waiting for resistance to spread. The country launched a Malaria Molecular Surveillance project that reads tiny changes in parasite DNA to spot resistance patterns before they become widespread.

The approach is already working. In March, researchers shared findings showing exactly where and how resistance is emerging across the country. These weren't just filed away in reports.

Key stakeholders including the Ministry of Health, WHO, UNICEF and health partners gathered to translate the data into immediate action. Some findings were incorporated into the newly developed National Malaria Strategic Plan while the evidence was still fresh.

Dr. Jane Achan, a principal advisor with Malaria Consortium, explained how genomic data reveals the tiny DNA changes that signal developing resistance. These microscopic clues help health officials make smart decisions about which drugs to use and where.

The team is now evaluating whether artesunate-amodiaquine should remain the first-line treatment for uncomplicated malaria. They're also expanding surveillance to understand how resistance varies across different provinces and monitoring mutations that could affect rapid diagnostic tests.

The Ripple Effect

In April, South Sudan took the collaboration further. Health officials, surveillance officers, academics and private sector representatives gathered for a co-design workshop in Juba to create practical, locally owned solutions.

They identified gaps in routine health reporting, community surveillance and drug resistance monitoring. Then they used a prioritization tool to focus on feasible, high-impact improvements that South Sudan can actually implement with existing resources.

The shift from identifying problems to designing homegrown solutions marks a new chapter in how the country tackles health challenges. Instead of waiting for resistance to overwhelm treatment options, South Sudan is building the surveillance systems to see it coming.

Dr. Denis Mubiru, Country Director for Malaria Consortium in South Sudan, noted that this evidence-based approach ensures national policy stays grounded in real-world conditions. When you can see resistance developing at the molecular level, you can change course before it's too late.

This proactive stance could protect millions of lives across a country where malaria remains one of the biggest killers, especially among children.